[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB9113038D0 - Novel treatment and compositions - Google Patents

Novel treatment and compositions

Info

Publication number
GB9113038D0
GB9113038D0 GB919113038A GB9113038A GB9113038D0 GB 9113038 D0 GB9113038 D0 GB 9113038D0 GB 919113038 A GB919113038 A GB 919113038A GB 9113038 A GB9113038 A GB 9113038A GB 9113038 D0 GB9113038 D0 GB 9113038D0
Authority
GB
United Kingdom
Prior art keywords
compositions
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919113038A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB919113038A priority Critical patent/GB9113038D0/en
Publication of GB9113038D0 publication Critical patent/GB9113038D0/en
Priority to AU21523/92A priority patent/AU2152392A/en
Priority to PCT/GB1992/001078 priority patent/WO1992022328A1/en
Priority to JP5500790A priority patent/JPH06508614A/en
Priority to CA002111583A priority patent/CA2111583A1/en
Priority to EP92913704A priority patent/EP0671949A1/en
Priority to PT100596A priority patent/PT100596A/en
Priority to ZA924427A priority patent/ZA924427B/en
Priority to MX9202931A priority patent/MX9202931A/en
Priority to IE196492A priority patent/IE921964A1/en
Priority to AU44498/96A priority patent/AU4449896A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
GB919113038A 1991-06-17 1991-06-17 Novel treatment and compositions Pending GB9113038D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB919113038A GB9113038D0 (en) 1991-06-17 1991-06-17 Novel treatment and compositions
EP92913704A EP0671949A1 (en) 1991-06-17 1992-06-16 USE OF $g(b)-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES
CA002111583A CA2111583A1 (en) 1991-06-17 1992-06-16 Use of b-cell-tropin (acth 22-39) antagonists in the treatment of type ii diabetes and associated diseases
PCT/GB1992/001078 WO1992022328A1 (en) 1991-06-17 1992-06-16 USE OF β-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES
JP5500790A JPH06508614A (en) 1991-06-17 1992-06-16 Use of β-cell tropin (ACTH22-39) antagonists in the treatment of type 2 diabetes and related diseases
AU21523/92A AU2152392A (en) 1991-06-17 1992-06-16 Use of beta -cell-tropin (acth 22-39) antagonists in the treatment of type ii diabetes and associated diseases
PT100596A PT100596A (en) 1991-06-17 1992-06-17 A method for the preparation of a pharmaceutical composition comprising a compound which regulates the formation, release or biological activity of the BETA cell line (BETA-CT), for example a specific antibody to BETA-CT), and the use of the compound reference for MEDICINES
ZA924427A ZA924427B (en) 1991-06-17 1992-06-17 Pharmaceuticals and use.
MX9202931A MX9202931A (en) 1991-06-17 1992-06-17 COMPOUND TO REGULATE THE FORMATION OF THE CELL BETA-TROPIN.
IE196492A IE921964A1 (en) 1991-06-17 1992-07-01 Pharmaceuticals and use
AU44498/96A AU4449896A (en) 1991-06-17 1996-02-13 Use of beta-cell-tropin (ACTH 22-39) antagonists in the treatment of type II diabetes and associated diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113038A GB9113038D0 (en) 1991-06-17 1991-06-17 Novel treatment and compositions

Publications (1)

Publication Number Publication Date
GB9113038D0 true GB9113038D0 (en) 1991-08-07

Family

ID=10696815

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919113038A Pending GB9113038D0 (en) 1991-06-17 1991-06-17 Novel treatment and compositions

Country Status (10)

Country Link
EP (1) EP0671949A1 (en)
JP (1) JPH06508614A (en)
AU (2) AU2152392A (en)
CA (1) CA2111583A1 (en)
GB (1) GB9113038D0 (en)
IE (1) IE921964A1 (en)
MX (1) MX9202931A (en)
PT (1) PT100596A (en)
WO (1) WO1992022328A1 (en)
ZA (1) ZA924427B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68924372T2 (en) * 1988-01-11 1996-05-09 Amylin Pharmaceuticals Inc TREATING DIABETES MELLITUS TYPE 2.

Also Published As

Publication number Publication date
MX9202931A (en) 1993-06-01
ZA924427B (en) 1993-06-23
AU2152392A (en) 1993-01-12
PT100596A (en) 1993-08-31
IE921964A1 (en) 1992-12-30
EP0671949A1 (en) 1995-09-20
JPH06508614A (en) 1994-09-29
AU4449896A (en) 1996-05-02
WO1992022328A1 (en) 1992-12-23
CA2111583A1 (en) 1992-12-23

Similar Documents

Publication Publication Date Title
GB9208339D0 (en) Treatment composition
IL104107A0 (en) New compounds and compositions
GB9121289D0 (en) Composition and use
HK1094148A1 (en) Synergistic therapeutic compositions and methods
GB9127150D0 (en) Novel treatment
HU9400190D0 (en) Therapeutic compositions and methods
GB9114526D0 (en) Compositions and use thereof
ZA919024B (en) Anthelmintic treatment and compositions
GB9007730D0 (en) Therapeutic compound and composition
GB9103631D0 (en) Composition and use
ZA916967B (en) Topical treatment and composition
GB9016027D0 (en) Composition and use
GB9113039D0 (en) Novel treatment and compositions
GB9113038D0 (en) Novel treatment and compositions
GB9113042D0 (en) Novel treatment and compositions
GB9113011D0 (en) Novel treatment and compositions
GB9120646D0 (en) Hair treatment composition
GB9113040D0 (en) Novel treatments and compositions
GB9113041D0 (en) Novel treatments and compositions
GB9022298D0 (en) Treatment composition
ZA919022B (en) Anthelmintic treatment and compositions
ZA923194B (en) Dental treatment compositions
ZA909765B (en) Vitamin-mineral treatment methods and compositions
GB9116906D0 (en) Composition and use
GB9105560D0 (en) Novel treatment i